CSHL organoid facility: Cancer custodians 7/2/2021 To beat our worst enemy, we must first let it grow. Read the story »
How pancreatic cancer cells dodge drug treatments 6/22/2021 CSHL scientists discovered a new clue that might explain how some pancreatic cancers evade cancer-killing drugs. Read the story »
Research matters 6/8/2021 Innovative research and educational activities never stopped during the COVID-19 pandemic. Read the story »
$11 million investment to develop fibroblast therapeutic 4/26/2021 CSHL Professor David Tuveson and other leading disease experts founded a company to target fibroblasts as a new way to treat cancer and inflammatory diseases. Read the story »
Dr. David Tuveson inaugurated as AACR president 4/21/2021 CSHL Cancer Center Director David Tuveson is leading the American Association for Cancer Research. Read the story »
CSHL’s new organoid facility 11/5/2020 The 2,200 square foot facility will make and maintain hundreds of live tissue models grown from patient tumors. Read the story »
One experiment: Organoids as living laboratories 10/30/2020 These tiny balls of cells are revolutionizing the research and treatment of pancreas and other types of cancers. Read the story »
New genetic research to understand racial disparity in cancers 9/8/2020 Cold Spring Harbor Laboratory will study the genetic contributions of ethnicity to colon, endometrial, and pancreas cancers in African Americans. Read the story »
Cold Spring Harbor Laboratory’s class of 2020 8/7/2020 Meet the seven graduates of the Cold Spring Harbor Laboratory School of Biological Sciences. Congratulations to all. Read the story »
Live @ the Lab with David Tuveson: Studying pancreatic cancer 7/29/2020 Cold Spring Harbor Laboratory Cancer Center Director Dave Tuveson presents an exciting new model for studying pancreatic cancer. Watch the video »
Cancer researchers discuss COVID-19’s effect on the field 7/27/2020 Dr. David Tuveson and Dr. Tobias Janowitz discuss in Cancer Discovery how the COVID-19 pandemic has changed cancer research. Read the story »
The first mouse model of human pancreas cancer subtypes 7/23/2020 CSHL researchers discovered how slow-growing pancreatic tumors can switch into a more deadly sub-type. Read the story »
Blocking cholesterol storage could stop growth of pancreatic tumors 7/7/2020 Interfering with the way pancreatic cancer cells process and store cholesterol can stop a tumor from growing. Read the story »
Applying symptom tracking to COVID-19 outpatient care using famotidine 6/4/2020 Researchers from CSHL and Northwell Health are developing a way to test promising COVID-19 drugs, like famotidine, by tracking outpatient symptoms. Read the story »
Tuveson and Wigler elected AACR Academy Fellows 5/12/2020 CSHL Cancer Center Director David Tuveson and Professor Michael Wigler were chosen as 2020 Fellows of the AACR Academy. Read the story »
